Xopenex
Product Images NDC 17478-172

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xop07 0005 01

Chemical structure of the active ingredient used in Xopenex, showing its molecular components including a phenol group, hydroxyl groups, and an amine with hydrochloride salt.*

FDA Label Image

Xop07 0005 02

A line graph showing mean change in FEV1 (%) over time (hours) for four groups: Lev 1.25, Lev 0.63, Bac 2.5, and PBO. The y-axis represents mean change in FEV1 (%) and the x-axis represents time in hours from 0 to 8. The graph compares respiratory function changes across these treatment groups.*

FDA Label Image

Xop07 0005 03

A line graph depicting mean change in FEV1 (%) over 8 hours across five treatment groups labeled Lev 1.25, Lev 0.63, Bas 2.5, PBO, and a control group. The x-axis represents time in hours, and the y-axis shows mean change in FEV1 (%), with each group tracked by distinct symbols and lines.*

FDA Label Image

Xop07 0005 04

A line graph depicting the mean change in FEV1 (%) over a 4-hour period post-dose for Xopenex at various doses (Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25) compared to placebo. The graph shows measurement points at multiple time intervals with a dashed line indicating a 15% change level.*

FDA Label Image

Xop07 0005 05

A line graph depicting mean change in FEV1 (%) over time (hours) for different doses and formulations, including Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and placebo (Pbo). The x-axis represents time in hours from 0 to 4, and the y-axis represents mean change in FEV1 percentage, from -5% to 30%. The graph compares responses by treatment group over the 4-hour period.*

FDA Label Image

Xop07 0005 06

An instructional illustration labeled 'X-top' showing how to twist off the tab on a vial. The image highlights the twist-off tab portion of the vial with shading and includes arrows indicating the direction to twist off the tab.*

FDA Label Image

Xop07 0005 07

An instructional diagram showing the top portion of a sachet or packet with an arrow pointing to the seam, labeled 'Tear at Seam,' indicating where to open the package. The image is likely part of usage or storage instructions for the Xopenex product by Akorn.*

FDA Label Image

Xop07 0005 08

An instructional diagram showing a hand holding a Xopenex inhaler, labeled 'X-top,' with an arrow indicating the direction to twist or remove the top part of the inhaler. The illustration focuses on the correct handling technique for the device.*

FDA Label Image

Xop07 0005 09

An instructional illustration showing a hand holding a vial and inserting it into the reservoir of a device. The vial and reservoir are labeled to indicate their parts in the assembly process.*

FDA Label Image

Xop07 0005 10

Illustration showing a medical device component labeled with a mouthpiece and reservoir, likely part of an inhaler or nebulizer setup for drug delivery.*

FDA Label Image

Xop07 0005 11

An instructional illustration showing a face mask connected to a reservoir, likely part of a medical or inhalation device setup. The image labels the "FACE MASK" and "RESERVOIR" components clearly.*

FDA Label Image

Xop07 0005 12

An illustration showing a section of a compressor device labeled 'COMPRESSOR' with a power knob and a rectangular display. Connected to the compressor is nebulizer tubing, labeled 'NEBULIZER TUBING,' which extends from the device.*

FDA Label Image

Xop07 0005 13

An instructional illustration showing a side profile of a person using an inhaler device labeled Xopenex by Akorn. The diagram points to the mouthpiece and reservoir parts of the inhaler where the medication is dispensed and inhaled.*

FDA Label Image

Xop07 0005 14

An instructional illustration showing a person wearing a face mask connected to a medicine reservoir, demonstrating the proper assembly or use of the inhalation device associated with Xopenex by Akorn.*

FDA Label Image

Xop07 0005 15

Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg/3 mL unit-dose vial label from Akorn. The label includes dosage strength, storage instructions, pharmacist attention note, and packaging information for 12 x 3 mL sterile unit-dose vials. The label also shows NDC 17478-172-12 and details about the distributor and manufacturer.*

FDA Label Image

Xop07 0005 16

Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution 0.31 mg/3 mL by Akorn. The label indicates this product contains 24 sterile unit-dose vials, each vial containing 3 mL of inhalation solution. The label shows the NDC 17478-172-24 and states it is for oral inhalation only, prescription use.*

FDA Label Image

Xop07 0005 17

Xopenex (levalbuterol HCl) Inhalation Solution 0.63 mg/3 mL sterile unit-dose vial label. The label provides dosage strength and administration form, specifying 12 x 3 mL sterile unit-dose vials. Distributed by Akorn, Inc. and manufactured for Oak Pharmaceuticals Inc. Includes storage instructions, usage warnings, and barcodes.*

FDA Label Image

Xop07 0005 18

Xopenex (levalbuterol HCl) Inhalation Solution 0.63 mg/3 mL carton packaging label by Akorn. The box contains 24 sterile unit-dose vials of 3 mL each. The label includes dosage strength, product name, labeler, NDC code 17478-173-24, and usage instructions indicating it is for oral inhalation only and Rx only.*

FDA Label Image

Xop07 0005 19

Xopenex (levalbuterol HCl) Inhalation Solution 1.25 mg/3 mL label showing a 12 x 3 mL sterile unit-dose vial package. Distributed by Akorn, Inc. and manufactured for Oak Pharmaceuticals Inc. Label includes storage, usage, and safety instructions along with barcodes and NDC 17478-174-12.*

FDA Label Image

Xop07 0005 20

Xopenex (levalbuterol HCl) Inhalation Solution 1.25 mg/3 mL by Akorn, presented in a carton containing 24 sterile unit-dose vials of 3 mL each. The label states it is for oral inhalation only and Rx only. Packaging includes NDC 17478-174-24 and features dosage strength prominently in red and white.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.